about
[Molecular tests in diagnosis of Cytomegalovirus (CMV), human herpesvirus 6 (HHV-6) and Epstein-Barr virus (EBV) using real-time PCR in HIV positive and HIV-negative pregnant women in Ouagadougou, Burkina Faso].Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina FasoSeroepidemiology of hepatitis B and C viruses in the general population of burkina faso.Effectiveness of the prevention of mother-to-child transmission of HIV protocol applied at Saint Camille Medical Centre in Ouagadougou, Burkina Faso.Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso.Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa.Effects of a cereal and soy dietary formula on rehabilitation of undernourished children at ouagadougou, in burkina faso.Importance of extending the use of polymerase chain reaction in the diagnosis of venereal syphilis in a blood transfusion center in Burkina Faso, West Africa[Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].Renin-Angiotensin System Genes Polymorphisms and Essential Hypertension in Burkina Faso, West AfricaAsymptomatic malaria correlates with anaemia in pregnant women at Ouagadougou, Burkina Faso.Antimicrobial resistance of abnormal vaginal discharges microorganisms in Ouagadougou, Burkina FasoPrevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso)Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West AfricaImproved neonatal survival through economically sustainable reorganization of a neonatal care unit in a developing country: 7-year experience in the Centre Medical Saint Camille (CMSC) of Ouagadougou, Burkina FasoCharacterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina FasoAnalysis of circulating populations of Plasmodium falciparum in mild and severe malaria in two different epidemiological patterns in Madagascar.A variant of DC-SIGN gene promoter associated with resistance to HIV-1 in serodiscordant couples in Burkina Faso.Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa.Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa.Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso.The Modalities of Nonadherence to Highly Active Antiretroviral Therapy and the Associated Factors Related to Patients' Sociodemographic Characteristics and Their Caregiving Perceptions in Ouagadougou (Burkina Faso).Enteric parasites prevalence at Saint Camille Medical Centre in Ouagadougou, Burkina Faso.HCV prevalence and co-infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou.HIV-infected women of Burkina Faso: a "reservoir" of mycoplasma infection.Antibiotic resistance in urinary tract bacteria in Ouagadougou.Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the Mother-to-Child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso.Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso.Factors predicting uptake of voluntary counselling and testing in a real-life setting in a mother-and-child center in Ouagadougou, Burkina Faso.Genotype characterization of human papillomavirus in women infected and uninfected with HIV in Ouagadougou, Burkina Faso.Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goalWorld Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination
P50
Q30394732-EC85D7DF-38A8-413F-A04D-A942A0171E26Q33682046-F4123B3B-5821-44EE-B204-58694FC44BD0Q34069016-86054213-3C09-4B7A-B6B0-46C748E817F5Q34477323-34C2A6E0-018D-447B-9D57-B6E064620DFCQ34651686-0406BBC5-52D5-4973-A0F5-D9A8203C26D8Q35024436-C59612FA-7708-4F42-AEF5-32FE21882767Q35127532-A765F86B-3C16-46BF-83C9-9BEA446042A8Q35585187-6D625864-9B3C-4C87-A8C1-3F8F0B15A5CBQ35759212-2AB19C0F-C587-4345-BE6B-192F3F1A6A24Q35916271-C29171B6-9D48-4EAE-9C2B-09AC41950BEDQ36006662-52AFF6C8-8A1D-4D71-B2BE-78C894E1CD57Q36438938-BFBEBD4D-883F-45B5-AB28-74990E40EAE7Q36719680-D90E3F85-D688-43B2-AFE3-C555D0961C73Q37208912-E11C6E2E-57A1-4881-AC84-3FF8CAFE197FQ37208916-406CB210-BE25-40DF-AB4B-3C83A0B8197EQ37350448-864D4325-8714-47A5-B3F5-699C7D1B5677Q37602315-7AEC39C6-0AE3-4239-A8E0-5361F653B481Q41441943-C2904CEC-135B-4AAB-95D8-D825C835EA90Q41702911-09218BCA-2C47-40A2-825B-00D7BFDEA483Q42284412-CA0A6B57-E444-422F-B2AD-BB33CCB02E51Q42909682-72B1FE81-964D-46B2-81E3-BE8E324D5968Q42968722-018C1C6A-9C97-4859-B221-816F3FE9EB15Q42986663-F05111B2-B9BA-4A44-BA15-7B4AC3ED0B72Q43925807-45A66B50-2B51-4D7B-8564-B320B6FBBD95Q43930174-0B56A894-A062-4DE7-A474-5C3292CD6356Q43930193-C998F062-685C-4633-AA59-4381291B1D83Q43930384-A1464EAE-5408-4909-BA0C-A75F28550445Q43931527-632EF632-F286-4295-A6C7-BD8CBE905E1EQ43932546-3497306F-947B-4DF7-9602-09237568E662Q43933225-E797E80A-86EF-42D7-8502-28D6369E3F08Q43933263-C514D240-2909-47FA-9074-41A801674CF0Q45912461-A7694B9C-8E92-466E-880B-16B24872A522Q47554776-438707BD-C630-44FB-B541-9FD39F8D379FQ56334878-3BB9E4E7-89C2-4B25-971E-7CFAE08BC7C7Q56828807-262E2523-A8C4-4C5A-B237-90FA86FC5CA7
P50
name
Virginio Pietra
@ast
Virginio Pietra
@en
Virginio Pietra
@es
Virginio Pietra
@nl
type
label
Virginio Pietra
@ast
Virginio Pietra
@en
Virginio Pietra
@es
Virginio Pietra
@nl
prefLabel
Virginio Pietra
@ast
Virginio Pietra
@en
Virginio Pietra
@es
Virginio Pietra
@nl